The HSPB6 knockout HEK293T polyclonal cells comprise a CRISPR/Cas9-edited polyclonal knockout cell population with targeted disruption of the HSPB6 gene. This loss-of-function model in the HEK293T background eliminates functional HSPB6 protein, enabling detailed study of its roles in stress response and apoptosis. The polyclonal format ensures a genetically diverse pool, mitigating clonal selection artifacts and providing a robust system for functional genomics and signaling research. As a polyclonal population, it retains the broad applicability of the HEK293T host while abrogating HSPB6 function.
The HEK293T cell line, derived from human embryonic kidney cells transformed with adenovirus 5 DNA, stably expresses the SV40 large T antigen. Its high transfectability and support for episomal replication make it ideal for protein production, viral generation, and signaling research.
HSPB6, also known as Hsp20, is a small heat shock protein functioning as a molecular chaperone with key roles in cardioprotection, smooth muscle relaxation, and apoptosis regulation. cAMP activates PKA catalytic subunits, which phosphorylate HSPB6 at Ser16. Phosphorylated HSPB6 interacts with 14-3-3 proteins, a critical step that stabilizes the actin cytoskeleton by associating with actin and alpha-actinin. Separately, HSPB6 binds directly to the pro-apoptotic protein Bax, preventing its mitochondrial translocation and thereby inhibiting caspase cascade activation. Additional downstream effectors include Bcl-2 family proteins. Upstream stimuli such as heat shock and oxidative stress further modulate HSPB6 expression and activity, integrating multiple stress signals.
Applying this knockout model in HEK293T cells offers a unique opportunity to study HSPB6 function outside the cardiac and smooth muscle systems where it is typically examined. The transformed renal epithelial background of HEK293T provides a context for investigating apoptosis resistance and cytoskeletal regulation relevant to cancer biology. Elimination of endogenous HSPB6 allows unambiguous assignment of protein interactions and signaling dependencies, facilitating quantitative structure-function studies and pharmacological interrogation of the HSPB6 pathway. Moreover, co-expression experiments with mutant HSPB6 constructs can further delineate phosphorylation-dependent versus -independent functions.
This polyclonal knockout cell pool is well suited for diverse research applications, including cardioprotection mechanisms, apoptosis resistance in cancer, smooth muscle relaxation biology, and cellular stress responses. Researchers can employ western blotting to monitor HSPB6 and phospho-HSPB6(Ser16) levels, co-immunoprecipitation assays to confirm interactions with 14-3-3 and alpha-actinin, and actin binding assays to assess cytoskeletal remodeling. Functional readouts such as caspase activation and Annexin V staining provide quantitative measures of apoptosis. Additionally, stimulation with cAMP analogs followed by phospho-signaling analysis enables mapping of upstream regulatory events. These cells provide an essential tool for target validation and pathway dissection in signal transduction and drug discovery. For further information, please contact Ascent Research.
